Why is Windlas Biotech falling/rising?

As of 14-Jul, Windlas Biotech Ltd's stock price is rising, currently at Rs 914.50, reflecting an increase of Rs 16.05 or 1.79%. The stock has shown a trend reversal, gaining after two consecutive days of decline, and it reached an intraday high of Rs 929.5, which is a 3.46% increase. Despite a recent decline over the past month of 2.18%, the stock has performed well over the past year, generating a return of 30.04%. Positive factors contributing to the stock's rise include an increase in institutional investor participation, which has grown by 0.6% in the last quarter, and the company's consistent returns over the last three years, outperforming the BSE500 index. However, the stock is trading at a premium compared to its peers, and there are concerns about long-term growth due to a relatively low operating profit growth rate.
Broader market context indicates that Windlas Biotech's short-term performance has outperformed the benchmark Sensex, which has declined by 1.42% over the past week while Windlas Biotech has increased by 0.66%. This suggests that the stock is gaining traction despite broader market challenges. The company's low debt-to-equity ratio and fair valuation metrics, alongside a solid return on equity of 12.1%, further support its current price movement. However, the stock's liquidity is somewhat constrained, as indicated by a significant drop in delivery volume, which may affect future trading dynamics.